Neuraxis NRXS
NYSE NRXS
$6.15 -0.12 (-1.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Net Income (2022 - 2025)

Neuraxis (NRXS) posted Net Income of -$1.7 million for Q4 2025, up 20.96% sequentially from -$2.1 million in Q3 2025, and down 26.71% YoY from -$2.3 million in Q4 2024.

Neuraxis (NRXS) Net Income (2022 - 2025) Analysis & Trends

Neuraxis has reported Net Income for 4 years, with the latest figure at -$1.7 million in Q4 2025.

  • Quarterly Net Income fell 26.71% year-over-year to -$1.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$5.9 million (up 27.32% YoY) and the FY2025 annual result came in at -$8.2 million, down 5.87% from the prior year.
  • Net Income climbed to -$1.7 million in Q4 2025 per NRXS's latest filing, from -$2.1 million in the prior quarter.
  • Over five years, Net Income peaked at -$704032.0 in Q2 2022 and troughed at -$3.1 million in Q3 2023.
  • A 4-year average of -$1.7 million and a median of -$1.7 million in 2025 frame the typical range for Net Income.
  • The sharpest annual moves came in 2023 and 2024: Net Income tumbled 139.51% in 2023, then jumped 45.05% in 2024.
  • Over 4 years, Net Income stood at -$1.0 million in 2022, then plunged by 58.07% to -$1.6 million in 2023, then increased by 18.22% to -$1.3 million in 2024, then slipped by 26.71% to -$1.7 million in 2025.
  • According to Business Quant data, Net Income over the past three periods registered -$1.7 million, -$2.1 million, and -$2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 482.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -13.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Neuraxis 74.54 Mn 66.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.68 Mn
Sep 30, 2025 -2.13 Mn
Jun 30, 2025 -2.09 Mn
Mar 31, 2025 -2.30 Mn
Dec 31, 2024 -1.33 Mn
Sep 30, 2024 -1.72 Mn
Jun 30, 2024 -2.78 Mn
Mar 31, 2024 -1.86 Mn
Dec 31, 2023 -1.62 Mn
Sep 30, 2023 -3.12 Mn
Jun 30, 2023 -1.31 Mn
Mar 31, 2023 -1.06 Mn
Dec 31, 2022 -1.03 Mn
Sep 30, 2022 -1.30 Mn
Jun 30, 2022 -704,032.00